KdT Ventures

Koch Disruptive Technologies is a venture capital firm within Koch Industries, focused on investing in transformative companies across various stages and industries. KDT partners with innovative companies that leverage advanced technologies to create significant economic and societal impacts. The firm’s investment strategy is sector-agnostic, including notable areas like biotechnology, health tech, agriculture, and AI. Some prominent companies in their portfolio include PathAI, which improves pathology diagnostics using AI, and Solugen, which creates environmentally-friendly chemicals through enzymatic reactions. Other investments include Terray Therapeutics, focusing on novel treatments for human diseases, and Andes, which develops bio-based agricultural solutions to enhance crop production. KDT provides more than just financial backing. They offer strategic guidance and leverage Koch Industries’ extensive network to help portfolio companies scale and succeed. The team at KDT includes professionals with diverse expertise, providing valuable support in navigating market challenges and accelerating growth.